Close Menu

NEW YORK – Finnish medical device manufacturer ArcDia International said on Monday that its automated SARS-CoV-2 antigen point-of-care test has received CE marking and is commercially available. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.